Apollo Hospitals Enterprise share news, announcements and annual reports
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.
30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00
52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,469 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.13
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,72,15658.2% delivered
Apollo Hospitals Enterprise share news and announcements
863 announcements, routine notices left out, newest first. Page 6 of 18.
Oct 2022
31 Oct · Analysts
12 Oct · General updates
5 Oct · Business
Aug 2022
9 Aug · Analysts
3 Aug · Business Responsibility & Sustainability Report (BRSR)
3 Aug · Meeting
Jul 2022
16 Jul · General updates
16 Jul · Board meeting
16 Jul · Meeting
6 Jul · General updates
Jun 2022
9 Jun · Related Party Transaction
9 Jun · General updates
May 2022
25 May · Dividend
25 May · Management
25 May · Results
23 May · Analysts
Apr 2022
7 Apr · General updates
Mar 2022
16 Mar · Business
Feb 2022
11 Feb · Limited Review Report
11 Feb · Results
10 Feb · Analysts
1 Feb · Rating
Jan 2022
28 Jan · Analysts
28 Jan · Updates
Dec 2021
Nov 2021
18 Nov · Meeting
12 Nov · Limited Review Report